COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo
Piramal acquires Coldstream Laboratories Inc., USA, a sterile injectable manufacturer
Feb, 2015
Piramal Pharma Solutions Receives 4 CMO Awards
Jan, 2015
Sterile Injectable Formulations – A challenging yet rewarding market
Dec, 2014
Clinical Trial Supplies – Strategies To Address Operational Challenges
Oct, 2014
119 US FDA approved manufacturing sites and growing… India – The Global Pharmaceutical Manufacturing Destination
Aug, 2014
Green Chemistry at Piramal healthcare
Aug, 2014